Dentritic Cell Therapy - Restoring Immune Recognition in Cancer

The science and clinical application of Dendritic Cell Therapy

Feb 28, 2026

∙ Paid

Cancer is not simply uncontrolled growth. It is a failure of immune recognition.

For decades, cancer has been described primarily as a disease of proliferation; mutations accumulating, cells dividing rapidly, and tumors expanding. That description is not wrong, but it is incomplete.

Abnormal cells arise in the body every day. What determines whether they …

Continue reading this post for free, courtesy of Amanda King ND.

Or purchase a paid subscription.

A guest post by

Janet Maendel DO(EU)

Janet Maendel DO(EUR) is an integrative oncology clinician whose work centers on immunometabolism & metabolic approaches to cancer care. She explores clinical reasoning, data interpretation, and the biological context beneath diagnosis.